Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech announces that the earn-out conditions in respect of its acquisition of IVDeology Holdings Ltd, originally announced on 7 May 2024, have been satisfied.</li>
<li>Pursuant to the terms of the share purchase agreement, earn-out consideration of £200k has become payable following the achievement of the maximum revenue target for the two-year earn-out period following acquisition.</li>
<li>Accordingly, the Earn-out Consideration will be satisfied by the issue of new ordinary shares in the Company to the vendors, Stuart Angell and Nancy Consterdine.</li>
</ul>


The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech announces that the earn-out conditions in respect of its acquisition of IVDeology Holdings Ltd, originally announced on 7 May 2024, have been satisfied.
Pursuant to the terms of the share purchase agreement, earn-out consideration of £200k has become payable following the achievement of the maximum revenue target for the two-year earn-out period following acquisition.
Accordingly, the Earn-out Consideration will be satisfied by the issue of new ordinary shares in the Company to the vendors, Stuart Angell and Nancy Consterdine.


Abingdon Health

Hybridan Small Cap Feast: 19 May 2026